StockData
Pfizer Inc logo

Pfizer Inc

PFENYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Aug 4, 2026Score 11/3053% above fair value
$30.67+0.15 (+0.49%)

Close on Nov 2, 2026Market cap $174.81BP/E 40.4Yield 5.61%

Pfizer Specialty Care Portfolio Total [legacy pre-Q1 2026 by Quarter

Specialty Care Portfolio Total [legacy pre-Q1 2026 realignment, through Q4 2025] ($M) ($M)

QuarterlyAnnual

Pfizer Specialty Care Portfolio Total [legacy pre-Q1 2026: $4,771M in Q4 2025, up 7.5% from a year earlier. That is the highest of the 18 quarters on record here.

Latest, Q4 2025
4,771
Period ended Dec 31, 2025
Change on a year earlier
+7.5%
4,438 in Q4 2024
History
18 quarters
Since Q3 2021
Sources
14
Documents cited below

Where the Q4 2025 figure comes from

“|| Specialty Care | $ | 4,771 | $ | 4,438 | 8% | 6% | $ | 2,157 | $ | 2,079 | 4% | $ | 2,614 | $ | 2,359 | 11% | 8%”

Source: Form 8-K (Earnings / Guidance Release) (pfe-12312025xex99.htm, filed 2026-02-03) ↗

Reported in Form 8-K Revenue Tables & Form 10-K Segment Note.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedSpecialty Care Portfolio Total [legacy pre-Q1 2026 realignment, through Q4 2025] ($M) ($M)Year on yearSource
Q4 2025Dec 31, 20254,771+7.5%Form 8-K (Earnings / Guidance Release) (pfe-12312025xex99.htm, filed 2026-02-03) ↗
Q3 2025Sep 28, 20254,411+2.8%Form 8-K (Earnings / Guidance Release) (pfe-09282025xex99.htm, filed 2025-11-04) ↗
Q2 2025Jun 29, 20254,378+7.2%Form 8-K (Earnings / Guidance Release) (pfe-06292025xex99.htm, filed 2025-08-05) ↗
Q1 2025Mar 30, 20253,987+3.7%Form 8-K (Earnings / Guidance Release) (pfe-03302025xex99.htm, filed 2025-04-29) ↗
Q4 2024Dec 31, 20244,438+12.3%Form 8-K (Earnings / Guidance Release) (pfe-12312025xex99.htm, filed 2026-02-03) ↗
Q3 2024Sep 29, 20244,289+14.0%Form 8-K (Earnings / Guidance Release) (pfe-09282025xex99.htm, filed 2025-11-04) ↗
Q2 2024Jun 30, 20244,083+11.7%Form 8-K (Earnings / Guidance Release) (pfe-06292025xex99.htm, filed 2025-08-05) ↗
Q1 2024Mar 31, 20243,843+6.3%Form 8-K (Earnings / Guidance Release) (pfe-03302025xex99.htm, filed 2025-04-29) ↗
Q4 2023Dec 31, 20233,953+10.9%Form 8-K (Earnings / Guidance Release) (pfe-12312024xex99.htm, filed 2025-02-04) ↗
Q3 2023Oct 1, 20233,763+10.5%Form 8-K (Earnings / Guidance Release) (pfe-9292024xex99.htm, filed 2024-10-29) ↗
Q2 2023Jul 2, 20233,656+8.9%Form 8-K (Earnings / Guidance Release) (pfe-6302024xex99.htm, filed 2024-07-30) ↗
Q1 2023Apr 2, 20233,616+3.2%Form 8-K (Earnings / Guidance Release) (pfe-3312024xex99.htm, filed 2024-05-01) ↗
Q4 2022Dec 31, 20223,566-10.6%Form 8-K (Earnings / Guidance Release) (pfe-12312023xex99.htm, filed 2024-01-30) ↗
Q3 2022Oct 2, 20223,404-9.2%Form 8-K (Earnings / Guidance Release) (pfe-10012023xex99.htm, filed 2023-10-31) ↗
Q2 2022Jul 3, 20223,358–Form 8-K (Earnings / Guidance Release) (pfe-07022023xex99.htm, filed 2023-08-01) ↗
Q1 2022Apr 3, 20223,505–Form 8-K (Earnings / Guidance Release) (pfe-04022023xex99.htm, filed 2023-05-02) ↗

Breakdown

What makes up specialty Care Portfolio Total [legacy pre-Q1 2026

Cite this data

StockData. (2026). Pfizer Specialty Care Portfolio Total [legacy pre-Q1 2026 ($M), quarterly Q3 2021–Q4 2025 [Data set]. Compiled from Pfizer SEC filings and investor materials. https://stockdatahq.com/stocks/pfe/kpis/port-leg-sc-ww

See every metric in the Pfizer KPI table. Data updated Nov 2, 2026.